Spirea is at the forefront of revolutionising cancer and beyond with our cutting-edge ELIVATE linker technology. Our innovative approach significantly expands the payload repertoire for antibody-drug conjugates (ADCs), enabling the next generation of targeted therapies. By leveraging ELIVATE’s multivalent capabilities, we optimise therapeutic outcomes, ensuring precise drug delivery and enhanced pharmacokinetics. Our dedicated team of experts is committed to advancing our proprietary ADC pipeline and forming strategic partnerships to maximise the potential of our technology. Join us on our mission to transform patient care and deliver groundbreaking treatments across a wide range of diseases. Explore how Spirea is unlocking the full potential of ADCs at www.spirea.co.uk
| Website | http://www.spirea.co.uk |
| Employees | 8 (4 on RocketReach) |
| Founded | 2015 |
| Phone | +33 1 41 19 27 72 |
| Industry | Biotechnology Research, Drug Discovery, Pharmaceuticals |
| Keywords | Antibody Drug Conjugates, Cancer Treatment, Adc Technology, Oncology, Drug Development, Immuno Oncology, Biotechnology, Targeted Therapy, Cancer Research, Pharmaceutical, Precision Medicine, Therapeutic Antibodies, Drug Discovery, Biopharma, Clinical Trials, Medical Technology, Pharmaceutical Research, Life Sciences |
| Competitors | Johnson & Johnson, Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb +43 more (view full list) |
Looking for a particular Spirea employee's phone or email?
Spirea Questions
Myriam Ouberai is the Founder and CSO of Spirea.
4 people are employed at Spirea.
Top Spirea Employees
Related Companies
